The Lubrizol Corporation-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:The Lubrizol Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014201
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
The Lubrizol Corporation (Lubrizol), a subsidiary of Berkshire Hathaway Inc., is a specialty chemical company that produces and supplies technologies to the global transportation, industrial, and consumer markets. Its products and services include engine additives, driveline additives, industrial specialties products, engineered polymers, coatings, and life science solutions. Lubrizol’s products find application in engine oils, transmission fluids, gear oils, metalworking fluids, compressor lubricants, specialty driveline lubricants, fuel additives, pipelines, greases for transportation and industrial applications, over-the-counter pharmaceutical products, performance coatings, personal care products, sporting goods and plumbing and fire sprinkler systems. The company operates through a network of manufacturing facilities, laboratories, sales offices and technical offices in countries across North America, Europe and Asia-Pacific. Lubrizol is headquartered in Wickliffe, Ohio, the US.

The Lubrizol Corporation – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
The Lubrizol Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
The Lubrizol Corporation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
The Lubrizol Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
The Lubrizol Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
The Lubrizol Corporation, Medical Devices Deals, 2011 to YTD 2017 9
The Lubrizol Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
The Lubrizol Corporation, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Particle Sciences Enters Into Licensing Agreement With Lyotropic Therapeutics For Drug Delivery Technology 11
IDP Discovery Pharma Enters into Collaboration Agreement with BCN Peptides 12
Particle Sciences Enters Into Co-Development Agreement With Actavis 13
Particle Sciences Enters Into Co-Development Agreement With Pernix Therapeutics 14
Austen BioInnovation Institute Enters Into Technology Integration Agreement With The Lubrizol 15
Particle Sciences Enters Into An Agreement With Absorption Systems 16
Hovione Enters Into Co-Development Agreement With Particle Sciences 17
ProRetina Therapeutics And GP Pharm Enter Into Joint Venture With BCN Peptides 18
Licensing Agreements 19
Glenmark Pharma Enters into Licensing Agreement with Particle Sciences 19
Acquisition 20
Lubrizol Acquires Particle Sciences 20
Lubrizol Completes Acquisition Of Lipotec, Supplier Of Over The Counter Products 21
Lubrizol Completes Acquisition Of Active Organics 23
The Lubrizol Corporation – Key Competitors 24
The Lubrizol Corporation – Key Employees 25
The Lubrizol Corporation – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 29
Strategy And Business Planning 29
Jan 19, 2017: Lubrizol Skin Care Actives Combine Under One Name in North America 29
Corporate Communications 30
Jan 03, 2017: Eric R. Schnur Succeeds James L. Hambrick as Lubrizol Chairman and CEO 30
Other Significant Developments 31
Jun 06, 2017: Lubrizol Invests $60 Million to Expand Particle Sciences, Vesta and Other Facilities in 2017 31
Apr 04, 2017: Lubrizol Skin and Dermal Care Integrate to Form Lubrizol Skin Essentials 32
Feb 07, 2017: Lubrizol LifeSciences Announces New Compounding Capabilities 33
May 31, 2016: Particle Sciences, a part of Lubrizol LifeSciences, Adds Sterile Powder Filling and Capsule Filling Capabilities 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
The Lubrizol Corporation, Pharmaceuticals & Healthcare, Key Facts, 2016 2
The Lubrizol Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
The Lubrizol Corporation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
The Lubrizol Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
The Lubrizol Corporation, Deals By Therapy Area, 2011 to YTD 2017 8
The Lubrizol Corporation, Medical Devices Deals, 2011 to YTD 2017 9
The Lubrizol Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Particle Sciences Enters Into Licensing Agreement With Lyotropic Therapeutics For Drug Delivery Technology 11
IDP Discovery Pharma Enters into Collaboration Agreement with BCN Peptides 12
Particle Sciences Enters Into Co-Development Agreement With Actavis 13
Particle Sciences Enters Into Co-Development Agreement With Pernix Therapeutics 14
Austen BioInnovation Institute Enters Into Technology Integration Agreement With The Lubrizol 15
Particle Sciences Enters Into An Agreement With Absorption Systems 16
Hovione Enters Into Co-Development Agreement With Particle Sciences 17
ProRetina Therapeutics And GP Pharm Enter Into Joint Venture With BCN Peptides 18
Glenmark Pharma Enters into Licensing Agreement with Particle Sciences 19
Lubrizol Acquires Particle Sciences 20
Lubrizol Completes Acquisition Of Lipotec, Supplier Of Over The Counter Products 21
Lubrizol Completes Acquisition Of Active Organics 23
The Lubrizol Corporation, Key Competitors 24
The Lubrizol Corporation, Key Employees 25
The Lubrizol Corporation, Other Locations 26
The Lubrizol Corporation, Subsidiaries 26

★海外企業調査レポート[The Lubrizol Corporation-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sears Canada Inc:戦略・SWOT・企業財務分析
    Sears Canada Inc - Strategy, SWOT and Corporate Finance Report Summary Sears Canada Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • XCR Diagnostics Inc:企業の製品パイプライン分析
    Summary XCR Diagnostics Inc (XCR Diagnostics) is a designer and developer of real-time PCR assays. The company’s products include brucella abortus detection assay, brucella ovis detection assay and custom real time PCR master mix. It offers services such as assay design services, assay design and co …
  • Valence Health-製薬・医療分野:企業M&A・提携分析
    Summary Valence Health is a healthcare company that provides healthcare services. The company offers solutions such as consulting, vision platform, quality measurement, cost and utilization, data collection, contract administration, managed services, and actuarial services. It provides health care s …
  • Mitsubishi Estate Co., Ltd. (8802):企業の財務・戦略的SWOT分析
    Mitsubishi Estate Co., Ltd. (8802) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Saudi Airlines Catering:企業の戦略・SWOT・財務分析
    Saudi Airlines Catering - Strategy, SWOT and Corporate Finance Report Summary Saudi Airlines Catering - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Tsumura & Co.:企業の戦略・SWOT・財務情報
    Tsumura & Co. - Strategy, SWOT and Corporate Finance Report Summary Tsumura & Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Chatham Lodging Trust:企業のM&A・事業提携・投資動向
    Chatham Lodging Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Chatham Lodging Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • CommScope Holding Company Inc (COMM):企業の財務・戦略的SWOT分析
    CommScope Holding Company Inc (COMM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • DocCheck AG (AJ91):企業の財務・戦略的SWOT分析
    DocCheck AG (AJ91) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Oman Telecommunications Company SAOG:企業の戦略・SWOT・財務情報
    Oman Telecommunications Company SAOG - Strategy, SWOT and Corporate Finance Report Summary Oman Telecommunications Company SAOG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Teleflex Inc (TFX):企業の財務・戦略的SWOT分析
    Teleflex Inc (TFX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Venado Oil & Gas LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Venado Oil & Gas LLC (Venado) is an oil and gas company that offers oil and gas services. The company explores and develops oil and natural gas properties in the Gulf Coast and Permian regions of Texas. It also provides crude oil and natural gas products. Venado offers services such as execu …
  • iCAD Inc (ICAD)-医療機器分野:企業M&A・提携分析
    Summary iCAD Inc (iCAD) is a medical device company. It develops and markets computer aided detection (CAD) solutions and workflow solutions for mammography (film-based, digital radiography (DR) and computed radiography (CR), Magnetic Resonance Imaging (MRI), and Computed Tomography (CT). iCAD produ …
  • Development Center for Biotechnology:製薬・医療:M&Aディール及び事業提携情報
    Summary Development Center for Biotechnology (DCB) is a non profit organization that offers support to biotechnology and pharmaceutical companies. The organization develops biotech industry through its cooperation and industrialization, key technologies, infrastructure building, research and develop …
  • Westar Energy Inc (WR):企業の財務・戦略的SWOT分析
    Westar Energy Inc (WR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Comvita Ltd (CVT):企業の財務・戦略的SWOT分析
    Comvita Ltd (CVT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Telefonaktiebolaget LM Ericsson (ERIC B):企業の財務・戦略的SWOT分析
    Telefonaktiebolaget LM Ericsson (ERIC B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Castle Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Castle Biosciences Inc (Castle Biosciences) is a drug development company that develops and commercializes diagnostic and prognostic tests for cancers. The company offers tests for cutaneous melanoma, uveal melanoma and glioblastoma multiforme. Its DecisionDx-melanoma identifies stage I or I …
  • Cardiac Science Corp:企業の戦略的SWOT分析
    Cardiac Science Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Omnicom Group Inc. (OMC):企業の財務・戦略的SWOT分析
    Omnicom Group Inc. (OMC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆